307 related articles for article (PubMed ID: 19252481)
1. Nicotine binding to brain receptors requires a strong cation-pi interaction.
Xiu X; Puskar NL; Shanata JA; Lester HA; Dougherty DA
Nature; 2009 Mar; 458(7237):534-7. PubMed ID: 19252481
[TBL] [Abstract][Full Text] [Related]
2. Secondary Ammonium Agonists Make Dual Cation-π Interactions in α4β2 Nicotinic Receptors.
Post MR; Tender GS; Lester HA; Dougherty DA
eNeuro; 2017; 4(2):. PubMed ID: 28589175
[TBL] [Abstract][Full Text] [Related]
3. Nicotinic pharmacophore: the pyridine N of nicotine and carbonyl of acetylcholine hydrogen bond across a subunit interface to a backbone NH.
Blum AP; Lester HA; Dougherty DA
Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13206-11. PubMed ID: 20616056
[TBL] [Abstract][Full Text] [Related]
4. Binding interactions with the complementary subunit of nicotinic receptors.
Blum AP; Van Arnam EB; German LA; Lester HA; Dougherty DA
J Biol Chem; 2013 Mar; 288(10):6991-7. PubMed ID: 23349463
[TBL] [Abstract][Full Text] [Related]
5. Using physical chemistry to differentiate nicotinic from cholinergic agonists at the nicotinic acetylcholine receptor.
Cashin AL; Petersson EJ; Lester HA; Dougherty DA
J Am Chem Soc; 2005 Jan; 127(1):350-6. PubMed ID: 15631485
[TBL] [Abstract][Full Text] [Related]
6. Two neuronal nicotinic acetylcholine receptors, alpha4beta4 and alpha7, show differential agonist binding modes.
Puskar NL; Xiu X; Lester HA; Dougherty DA
J Biol Chem; 2011 Apr; 286(16):14618-27. PubMed ID: 21343288
[TBL] [Abstract][Full Text] [Related]
7. Probing for and Quantifying Agonist Hydrogen Bonds in α6β2 Nicotinic Acetylcholine Receptors.
Post MR; Lester HA; Dougherty DA
Biochemistry; 2017 Apr; 56(13):1836-1840. PubMed ID: 28287260
[TBL] [Abstract][Full Text] [Related]
8. Variations in binding among several agonists at two stoichiometries of the neuronal, α4β2 nicotinic receptor.
Tavares Xda S; Blum AP; Nakamura DT; Puskar NL; Shanata JA; Lester HA; Dougherty DA
J Am Chem Soc; 2012 Jul; 134(28):11474-80. PubMed ID: 22716019
[TBL] [Abstract][Full Text] [Related]
9. Structural characterization of binding mode of smoking cessation drugs to nicotinic acetylcholine receptors through study of ligand complexes with acetylcholine-binding protein.
Rucktooa P; Haseler CA; van Elk R; Smit AB; Gallagher T; Sixma TK
J Biol Chem; 2012 Jul; 287(28):23283-93. PubMed ID: 22553201
[TBL] [Abstract][Full Text] [Related]
10. A triad of residues is functionally transferrable between 5-HT
Mosesso R; Dougherty DA
J Biol Chem; 2018 Feb; 293(8):2903-2914. PubMed ID: 29298898
[TBL] [Abstract][Full Text] [Related]
11. Defining the determinants of nicotine selectivity.
Taylor P
Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13195-6. PubMed ID: 20643924
[No Abstract] [Full Text] [Related]
12. An Accessory Agonist Binding Site Promotes Activation of α4β2* Nicotinic Acetylcholine Receptors.
Wang J; Kuryatov A; Sriram A; Jin Z; Kamenecka TM; Kenny PJ; Lindstrom J
J Biol Chem; 2015 May; 290(22):13907-18. PubMed ID: 25869137
[TBL] [Abstract][Full Text] [Related]
13. Cation-pi interactions in ligand recognition by serotonergic (5-HT3A) and nicotinic acetylcholine receptors: the anomalous binding properties of nicotine.
Beene DL; Brandt GS; Zhong W; Zacharias NM; Lester HA; Dougherty DA
Biochemistry; 2002 Aug; 41(32):10262-9. PubMed ID: 12162741
[TBL] [Abstract][Full Text] [Related]
14. Localization of agonist and competitive antagonist binding sites on nicotinic acetylcholine receptors.
Arias HR
Neurochem Int; 2000 Jun; 36(7):595-645. PubMed ID: 10771117
[TBL] [Abstract][Full Text] [Related]
15. Electrostatic Contributions to the Binding Free Energy of Nicotine to the Acetylcholine Binding Protein.
Li Z; Chan KC; Nickels JD; Cheng X
J Phys Chem B; 2022 Nov; 126(43):8669-8679. PubMed ID: 36260486
[TBL] [Abstract][Full Text] [Related]
16. Engineering α4β2 nAChRs with reduced or increased nicotine sensitivity via selective disruption of consensus sites in the M3-M4 cytoplasmic loop of the α4 subunit.
Biaggi-Labiosa NM; Avilés-Pagán E; Caballero-Rivera D; Báez-Pagán CA; Lasalde-Dominicci JA
Neuropharmacology; 2015 Dec; 99():273-84. PubMed ID: 25957813
[TBL] [Abstract][Full Text] [Related]
17. Role in the selectivity of neonicotinoids of insect-specific basic residues in loop D of the nicotinic acetylcholine receptor agonist binding site.
Shimomura M; Yokota M; Ihara M; Akamatsu M; Sattelle DB; Matsuda K
Mol Pharmacol; 2006 Oct; 70(4):1255-63. PubMed ID: 16868180
[TBL] [Abstract][Full Text] [Related]
18. Unraveling amino acid residues critical for allosteric potentiation of (α4)3(β2)2-type nicotinic acetylcholine receptor responses.
Wang ZJ; Deba F; Mohamed TS; Chiara DC; Ramos K; Hamouda AK
J Biol Chem; 2017 Jun; 292(24):9988-10001. PubMed ID: 28446611
[TBL] [Abstract][Full Text] [Related]
19. Enhanced inhibition of a mutant neuronal nicotinic acetylcholine receptor by agonists: protection of function by (E)-N-methyl-4-(3-pyridinyl)-3-butene-1-amine (TC-2403).
Papke RL
J Pharmacol Exp Ther; 2002 May; 301(2):765-73. PubMed ID: 11961083
[TBL] [Abstract][Full Text] [Related]
20. Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometry.
Indurthi DC; Qudah T; Liao VW; Ahring PK; Lewis TM; Balle T; Chebib M; Absalom NL
Pharmacol Res; 2019 Jan; 139():215-227. PubMed ID: 30472464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
